MiR-185 overexpression enhanced insulin secretion of pancreatic β-cells, promoted cell proliferation and inhibited apoptosis, suggesting that overexpressing miR-185 may serve a potentially promising and efficient therapeutic approach for DM [11]. Here, INS is linked to diabetes mellitus.